| # | Side effect | Count |
|---|---|---|
| 0 | OFF LABEL USE | 2019 |
| 1 | PRODUCT USE IN UNAPPROVED INDICATION | 1723 |
| 2 | MUCOSAL INFLAMMATION | 1111 |
| 3 | DRUG INEFFECTIVE | 1076 |
| 4 | GRAFT VERSUS HOST DISEASE | 915 |
| 5 | VENOOCCLUSIVE LIVER DISEASE | 875 |
| 6 | CYTOMEGALOVIRUS INFECTION | 873 |
| 7 | FEBRILE NEUTROPENIA | 863 |
| 8 | ACUTE GRAFT VERSUS HOST DISEASE | 826 |
| 9 | PYREXIA | 816 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | RHIZOBIUM RADIOBACTER BACTERAEMIA | 13 | 0.8667 |
| 1 | ACTINOMYCOTIC SEPSIS | 18 | 0.7200 |
| 2 | CYTOMEGALOVIRUS URINARY TRACT INFECTION | 20 | 0.6452 |
| 3 | SERTOLI-CELL-ONLY SYNDROME | 9 | 0.6000 |
| 4 | OVARIAN ATROPHY | 27 | 0.3214 |
| 5 | DONOR LEUKOCYTE INFUSION | 8 | 0.3200 |
| 6 | VIRAL HAEMORRHAGIC CYSTITIS | 198 | 0.2841 |
| 7 | CYSTITIS VIRAL | 97 | 0.2580 |
| 8 | DISSEMINATED TOXOPLASMOSIS | 29 | 0.2544 |
| 9 | AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME | 15 | 0.2542 |